Showing results (321-330 of 617) with videos related to

Sort By:
Pageof 62
Cancer Cell|April 9, 2008
Selective inhibition of JAK2-driven erythroid differentiation of polycythemia vera progenitorsIfat Geron, Annelie E Abrahamsson, Charlene F Barroga, et al.
British Journal of Cancer|May 17, 2018
Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancersJorge Cortes, Kenji Tamura, Daniel J DeAngelo, et al.
Leukemia|December 19, 2025
Solving Riddles Through Sequencing (SIRIUS): unlocking hematologic diagnoses by whole genome and transcriptome sequencingMarietta Truger, Manja Meggendorfer, Wencke Walter, et al.
Haematologica|February 14, 2007
Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor beta geneChristoph Walz, Georgia Metzgeroth, Claudia Haferlach, et al.
Leukemia|November 18, 2025
Long read nanopore DNA sequencing with adaptive sampling to identify tyrosine kinase fusion genesMatthew Salmon, Nicole Naumann, Jenny Rinke, et al.
Leukemia|July 15, 2023
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohortGeorgia Metzgeroth, Laurenz Steiner, Nicole Naumann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2021
Inotuzumab Ozogamicin for Relapsed/Refractory Acute Lymphoblastic Leukemia in the INO-VATE Trial: CD22 Pharmacodynamics, Efficacy, and Safety by Baseline CD22Hagop M Kantarjian, Wendy Stock, Ryan D Cassaday, et al.
JAMA|June 11, 2009
Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trialsJohn Koreth, Richard Schlenk, Kenneth J Kopecky, et al.
Leukemia Research|March 27, 2026
Clinical strategies for leukemia management: Recommendations from the Bridging the Gaps in Hematology Oncology Consensus Conference 2025Hetty E Carraway, Daniel J DeAngelo, Eunice S Wang, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Cardiovascular risk factors in myeloproliferative neoplasms: associations with survival and thrombotic outcomesJoan How, Orly Leiva, Robert Redd, et al.
Pageof 62